gly7
renin inhibitor
wall stiffness
dialysis
hf index
ivc
medical treatment
systolic function
dopamine
paf
clinic
endopeptidase inhibitor
sympathetic nervous system
hrv
inotropic effect
adenoviral
all cause mortality
tug test
time up & go test
ventilatory efficiency slope
bcl 2
mitochondrial complex v activity
tonometric
prodrug
acute care surgery
xo
xanthine oxidase inhibition
hemocompatibility
massive embolism
tm24/7
basic helix loop helix
terminal heart failure
atropine
biomedical
bmi
pressure overload induce heart failure
insulin receptor substrate 1
monoclonal antibody
correlate
refractory right heart failure
non invasively
functional class
surgeon
c statistic
hm
neprilysin inhibitor
chromatin hyperacetylation
rv decompensation
hscrp
pde2 inhibition
vasopressin
doxorubicin efflux transporter
leave ventricular diastolic function
cabg
hemodynamics
regression analysis
mva
severe heart failure
ventricular assist device
doppler
ef
pde
myocardial extracellular matrix
retn
heart transplantation
myofibre regeneration
oral
abdominal
arrhythmia
hyperkalemia
l type channel
diastolic fill formalism
ventricular fibrillation
insulin resistance
icd shock
lean body mass
zsf1
guanylate cyclase
dnx
clinical practice guideline
fat free mass
if channel inhibition
rest tension
discharge
composite primary outcome
right ventricular contractile reserve
contracting
dilated
nri
anesthetize
clcnka
antiplatelet medication
cxl 1020
atrial tachyarrhythmias
chronic hf
dilatation
prescription
leave ventricular dysfunction
sympathetic activity
gene induction
lv end diastolic dimension
ldl cholesterol
isoproterenol
right ventricular end diastolic area index
lad
adenosine
to + channel α subunit
noncardiovascular
prescribe
sympathetic tone
microrna
uninephrectomy
tgf β signal
leave atrial area
proteomic
pcwp
hypokalemia
auc
extubate
placebo
p38
medical
thromboembolism
inhospital
calreticulin
camp hydrolysis
transmitral
crt d
cardiac transplantation
cell
dilation
stress doppler echocardiography
polymerase ii
dna fragmentation
testosterone therapy
stenting
baroreflex sensitivity
rna
right ventricular pulmonary arterial coupling
hypertrophic
phospholamban
multivariable model
hh
adenine nucleotide
video edge detection
arm cuff
multivariable adjust hazard ratio
coronary perfusion
diastolic mitral leaflet motion
epicatechin rich cocoa
new york heart association class ii
multivariate cox proportional hazard regression modeling
thrombotic
precapillary ph
acs
hgb
diabete mellitus
chronic
cardiac volume
chromatin structure
rem2
neprilysin inhibition
intention to treat
adipose tissue
contractile response
erk1/2
antagonism
von willebrand factor
crt
angiotensin converting enzyme
apoptotic signal pathway
β2 receptor
diagnostic
intravenously
shock therapy
hf with reduce ejection fraction
acetyl lysine reader protein
cardiac sodium
contractile function
l dko
parasympathetic
pharmacologic
phenotype
hypoalbuminemia
cardiac mrna
dapc
vascular endothelial growth factor blockade
t score
cardiac index
neurohumoral
compensate hfpef
mitochondrial structure
outcome
gene expression
p70s6k ser \(411\)
heart failure with a reduce ejection fraction
surgically
heart mass
electrocardiographic q wave
sarcopenic range muscle waste
neurological
bpm
bypass
messenger rna
ventricular function
systolic ventricular function
cd34+vegfr2 + cell
right coronary artery
biopsy
percutaneous
randomize
intensive care unit
spontaneous vt
death
riα
af
renal disease
medicine
angiotensin convert enzyme
catheter ablation
cav1.2
post myocardial infarction
functional status
interatrial
epidemic
end stage renal disease
randomise control trial
sympathetic
cardioprotective
ec
systolic heart failure
fontan
valsartan
mitral valve
reverse remodeling
sarcomere
proangiogenic
testosterone supplementation
heart dilatation
incidence
chamber patterning
tunel
tolvaptan
doppler ultrasonography
fat mass
mix linear model
ischemic cardiomyopathy
lipolysis
vt
chronic kidney disease
aortic valve insufficiency
poc
ri
upr
general anaesthesia
circumferential strain
stent
physical therapy
spironolactone
angeli 's salt
rs
atherosclerotic
endothelial dysfunction
amyloidotic
qrs prolongation
vegf signal pathway
nyha functional class
pathogenesis
tricuspid
coronary disease
t1
endothelin
leave ventricular end diastolic pressure
primary composite endpoint
ulcer
electromechanical delay
intramuscular testosterone supplementation
cardiac output
chelation
lv fibrosis
cox model
6 minute walking distance
nyha class iii
metoprolol
tonometry
maximum oxygen consumption
end diastolic
preserve ejection fraction
mix method study
hypothermic circulatory arrest
palliative
expression
citrate cycle
decompensated heart failure
cardiac death
collagen
ejection fraction
rvpo
salt loading
cox hazard model
nanomolar
renin angiotensin aldosterone
snp
morpholino based
qrs morphology
exercise capacity
patient
transcatheter
leave atrial
systolic pressure
β adrenergic receptor blocker therapy
hhd
interquartile range
β blocker
mechanical cardiac support
renin angiotensin aldosterone pathway
dystrophin associated protein complex
circulatory
sa
repolarization
autonomic balance
perk
no
nt probnp
myocardial diastolic dysfunction
remodelling
atrial pacing
q66p
lcz696
quality of life
paf cpt
chronic obstructive pulmonary disease
tricuspid annular plane
platelet activating factor
sts
echo derived pulmonary arterial systolic pressure
xo inhibition
vagal tone
hno donor
catheterisation
arterial pressure
anaerobic threshold
electrocardiographic
transfusion
peripheral muscle
chronic pah
cardiomyocyte
mr
hfpef
new york heart association class
lp pla2
drug
pulmonary arterial vasculature
β blockade
skeletal muscle
pro brain type natriuretic peptide
aldosterone blockade
fractional flow reserve
functional mitral stenosis
wilcoxon match pair sign rank test
glomerular filtration rate
arterial elastance
cardiac dysfunction
serum cystatin c
excitation contraction
retrospective match cohort study
jugular
eds
ang ii infusion
baseline
chordal rupture
extend criterion cardiac transplant
mild hf
doppler echocardiography
cvd
refractory congestive heart failure
nurse practitioner
mena overexpression
leave ventricle end diastolic pressure
internist
organ
chest
bundle branch morphology
cardiac growth
l type voltage gated can \(2 +\) channel
composite end point
minimal detectable change
sphingosine 1 phosphate
high density lipoprotein
pulmonary congestion
c would
deg
il6
area under the receiver operate characteristic curve
pro b type np
pulseless ventricular fibrillation
echocardiographic
chromatin
shuttle walk test
lv end diastolic pressure
fluid overload
differential effect
end diastolic volume
dna
neurohormonal stimulation
leave ventricular diastolic end diameter
revascularization
meta analyse
fm
compensate lv hypertrophy
n2bus
abcc2
angii
angiotensin receptor blocker
β 1ar
rate control
inflammatory
cxl 1051
magnetic resonance spectroscopy
prospectively
circulate progenitor cell
adenovirus
blood pressure
ss
type 2 diabete
functional electrical stimulation
multivariable regression
systolic hf
cox regression
pna
evidence base
consultation
pef
acute coronary syndrome
fractional shortening
pluripotency marker
sitagliptin
antitumor
driveline
renal
vegf pathway
valve plasty
sympathetic outflow
uti
kinase 2
unfold protein response
cell death
adjust odd ratio
bax
negative binomial regression model
pro75
troponin t
creatine
proteome
blood cell
n terminal pro b type np
mena
epidemiology
ring annuloplasty
right atrium
dpp 4 inhibitor
electrolyte
hrqol
vascular
at
mena expression
nicorandil
alendronate
emd
idiopathic dilated cardiomyopathy
t2*
c kit + progenitor
cardiac stress
t1 mapping
aldosterone
kidney
adverse outcome
molecular pathway
pulmonary hypertension
lvas
cohort study
kcl ki
cardiovascular
r r interval
peripheral artery disease
heart sound
cardiac metabolic gene expression
lean mass quantification
palliative care
thromboembolic pulmonary hypertension
gly4
brachial systolic pressure
angiotensin ii infusion
respiratory gas analysis
sd of rr interval
myocardial fibrosis
non biological disease modify antirheumatic drug
tnf
cv
prevalence
glucose oxidation
invasive haemodynamic assessment
standard error of measurement
raf mek1/2 erk1/2 scaffold protein
mitochondrial proteome
leave atrial pressure
hyperinsulinemia
angiotensin receptor antagonist
transcription factor
antiadrenergic
compensatory hypertrophy
leave ventricular fill
β be
renin angiotensin aldosterone system inhibitor
diagnose
area under the curve
tachyarrhythmias
71ar
cardiovascular reserve
cs
enos ser \(1177\)
circulation
cellular metabolism
cd 133 + cell
hemodynamically
c terminally
mitogen activate protein kinase
shunting
ischemic mitral regurgitation
concentric leave ventricular hypertrophy
rad
titin hypophosphorylation
severe hf
cardiomyopathy
rac1
protein kinase
acute heart failure
unilateral renal denervation
embolize
systolic
tachypacing induce hf
cardiography
nonterminal epitope
's 12884
np
pathology
differential analysis
erythropoiesis
kidney failure
p.arg83gly
dacron patch closure
rest hr
transthoracic echocardiography
pah
cav1.3
orthotopic heart transplantation
lbbb
nitric oxide
exercise induce pasp
remote ischemic conditioning
dt
body mass index
maximal ventricular power index
riiα
terminal
nris
cyclase
medical history
postoperative
anemia
congestive hf
attrition
nyha iii
sacubiltril
kidney disease
physical
peak of 2
methylatropine
loop diuretics
hf
risk stratification
postischemic heart failure
diastolic mitral annular velocity
lv fill pressure
chronic end stage heart failure
renal function
cr
pkc βii
free wall rs
injection
autonomic imbalance
icc
surgical
re hospitalization
ffm
papillary muscle
echocardiograms
contemporaneous control group
fluorescence resonance energy transfer
myocarditis
pharmacological
btt
oedema
protein kinase r like er kinase
pro brain natriuretic peptide
nephrectomy
observational cohort study
tidal respiration
symptomatic adult fontan
adjuvant
subclinical
baroreflex
b type natriuretic peptide
implantable
lipoprotein
mena deletion
gene expression profile
anti oxidant defence
mitral fill flow
multivariate analysis
nondiabete
coronary intervention
ivabradine
exercise rehabilitation
peptide
chf nyha iiib
carvedilol
rheumatoid arthritis
atherosclerosis
serum creatinine
organic
sd
microarray
confidence interval
fibrosis
narrow qrs complex
6mwt
mitral
linear mixed model
doctor
ea
retrospective cohort
antitachycardia pacing
operative
microembolization
coronary microembolization induce hf
heart beat
angiography
pathological
diastole
tnf antagonist
symptomatic systolic heart failure
myocardial tissue
peripheral arterial disease
nosignificant
anterior leaflet
degenerative mitral valve
randomization
biomarker
mrna splice
acf
met
medical therapy
n terminal pro brain natriuretic peptide
condition
trastuzumab
pasp
lv end diastolic volume
ra
physiology
cystatin c
cardiac fill pressure
pharmaceutical
breathing
subproteome
ch
cardiopulmonary exercise test
liver
mesenchymal
dyssynchronous fail heart
sv
pacing induce dilated cardiomyopathy
euthanization
emergency department
mrna splicing
significance
health related quality of life
lv strain
multivariate adjust odd ratio
central venous pressure
cardiac overexpression
second generation sulfonylureas
transmitral blood flow velocity
paf acetylhydrolase
lv assist device
invasively
ami
blood
deficit index
drs
dilated lv
monocyte
camp signal
radiological
bisphophonate
cardiac apoptosis
sternotomy
histone acetyltransferase
decompensation
serum sodium
leave atrium
leave ventricular dd
hypertensive heart failure
hf with reduce ef
petco2
cardiopulmonary resuscitation
log rank
cardiovascular morbidity
nonmitochondrial
ankle brachial index
circumflex artery
saf
chronic pulmonary arterial hypertension
adenylyl cyclase
ras
cardiopulmonary
net reclassification improvement
cox proportional hazard analysis
gluconeogenesis
scaffold protein
clinician
vegf
postmenopausal
iron homeostasis
mitral valve area
icd
hf with preserve ef
fully magnetically levitate centrifugal flow chronic lvas
arterial
neurohormonal system
candesartan
nontrastuzumab user
complication
right heart circulatory failure
hct
plasma norepinephrine
midregional proanp
resistin
intubate
longitudinal rv fiber shortening
gastrointestinal bleed
cardiac plasma membrane
co primary outcome
leave ventricular systolic dysfunction
sickle cell disease
cgmp
pathophysiologically
anaerobic metabolism
gadolinium chelate contrast agent
dapc protein
erythropoiesis stimulating agent
magnetic resonance angiography
rehospitalization
edema
cachexia
right atrial pressure
structure telephone support
cardiogenic
total arterial compliance
cachectic heart failure
cyclic adenosine monophosphate
disease
fpassive
hereditary
chronic organ failure
cardiac energy metabolism gene expression
prescribing
pevk
chronic hfpef
prognostically
isoform
acute myocardial infarction
ecs
reduce leave ventricular ejection fraction
correlation coefficient
surgical palliation
ventricular myocyte
heart magnetic resonance imaging
apoptosis
coronary artery disease
dhand
nucleolin
coprimary outcome
biventricular
asymptomatic
tunel positive cell
heart transplant
polytetrafluoroethylene
cox proportional hazard model
interventricular
prospective study
aortic
beta1 adrenergic receptor
acute hf
eh
pressure overload hypertrophy
breast cancer
lvad therapy
cardiovascular death
emergency room
endothelial
dd
p38α
hospitalization
bromodomain protein
etidronate
hypertensive lv dysfunction
myocardial insulin resistance
immunoreactive
eplerenone
haematopoietic cell transplantation
troponin i
heart failure with preserve ejection fraction
congestive heart failure
mitochondrial function
continuity equation
akt→forkhead box class o 1 signal
atrioventricular delay
rehabilitation
spontaneous ventricular tachycardia
bottleneck stent
vasopressin receptor antagonist
neuro hormonal
catecholamine
ka renal chloride channel gene
life expectancy
pressure ulcer
lyso paf acetyltransferase
peak respiratory quotient
rrna transcription
lv contractility
parasympathetic activity
symptomatic chronic advanced heart failure
hemolysis
annular ms
cardiac amyloidosis
preserve lvef
degenerative mitral regurgitation
cα
plasma catecholamine
mitral valve plasty
ser77
interaction term analysis
coronary artery bypass grafting
hr
nyha classification
signal protein
ventricular action potential
rm
continuous wave doppler echocardiography
third heart sound
concentric remodeling
logistic regression
osteomedullary biopsy
hypertensive
sulfonylureas
pro2
lv end systolic volume
antibody
bnp
morbidity
psoriasis
tumor necrosis factor
obese
albumin
explant
tapse
z score
breathlessness
radial strain
cardioverter defibrillator device
mrnas
bioprosthetic aortic valve replacement
right ventricular fractional area
human to human contact
mi
neuronal stressor
lung
post lvad be
leave bundle branch block pattern
β2 adrenergic receptor haplotype
neurohormonally
trpm7
plasma n terminal pro b type natriuretic peptide
myocardial angiogenesis
brain
rmsea
radial arterial tonometry
myofiber shortening
extracellular matrix
protein
mrna
diastolic failure
adverse event
bb
diagnosis
cerebrovascular
mechanical circulatory support
undiagnosed
aortocaval fistula
estimate glomerular filtration rate
polymorphism
sh
diastolic mitral valve tethering
vasopressin type 2 receptor antagonist
leave anterior descend coronary artery occlusion
cardiac fill
dpp 4
pump thrombosis
health care
bcl2
inverse correlation
st2
univariable analysis
lv mass
gut
coronary artery bypass
transcriptional pause release
heart rate variability
lv reverse remodeling
doxorubicin
incremental shuttle walk test
multivariate logistic regression analysis
at1 receptor
cardiogenic shock
mr proadm
phosphorylation
lv fractional shortening
myocardial t1
new york heart association functional class
nodularity
reduce ef
specificity
chronic renal failure
rct
remodeling
adiponectin
longitudinal
preserve ef
intestinal dysfunction
lv dilatation
mdc
immunoassays
epicatechin
cfi
ms
tgf β
stenosis
plasma nps
myocardial washout
pf
peak oxygen consumption
beta receptor blocker
postoperatively
renal dysfunction
β be responsiveness
6 minute hall walk
lyso paf at
fes
qt variability
valvular
cha₂ds₂vasc score
dual x ray absorptiometry
diastolic stiffness
intravenous bolus
thr197
renin
concentric hypertrophy
coronary artery bypass surgery
titin
leave anterior descend artery
diastolic blood pressure
atrial explant
shunt
afterload
atrium
myocyte depolarization
collagen cross linking
heart disease
severe systolic heart failure
pulmonary arterial pressure
leukocyte
nephropathy
defibrillation
lv internal diameter
central glycosylated region
furosemide
x ray
renal dnx
diastolic mitral annulus velocity
echocardiography
rankin score
tricuspid annular plane systolic excursion
sternal
functional enrichment analysis
phenylephrine mediated hypertrophy
gata4
followed up
hospital
ie
af ablation
autologous
cardiac troponin t
heart specific irs1 and irs2 gene double knockout
heterochromatic chromatin
hypotension
mortality
ss 20
angiotensin receptor neprilysin inhibitor
exercise intolerance
heart iron
descriptive statistic
cardioverter defibrillator
coronary angiography
in vitro
exercise oscillatory ventilation
exercise induce pulmonary artery systolic pressure
hemodynamic
lv relaxation
new york heart association class i
cardiac arrest
post hoc analysis
aetiology
s '
bisoprolol
cross talk
allogeneic
thalassaemia major
relative wall thickness
misdiagnosis
meta analysis
tricuspid valve
biventricular dysfunction
lv ejection fraction
bromodomain
dyssynchronous nonfailing
rv support
right ventricular pressure overload
transgenic
peritoneal dialysis
metabolic pathway
coronary artery
nuclear factor κb
pioglitazone
cardiac angiogenesis
anti inflammatory
cardiac remodeling
ven / vco2 slope
ca2 \(+\)
contractility
extracellular flux analyzer
medication
gadolinium chelate
diastolic
ischaemia
type i regulatory subunit
significantly
bone morphogenetic protein 4
all cause readmission
rest hemodynamics
cox regression model
crf
ischemic hf
renin angiotensin aldosterone system
flow mediate dilatation
bisphosphonate
α myosin heavy chain
mitochondrial oxidative metabolism
volume overload
bivp
cardiac chromatin
raf mek1/2 erk1/2 signal pathway
guideline direct medical therapy
mitochondrial oxidation
pro bnp
dyssynchronous heart failure
skm
severe systolic hf
tachycardic
stroke volume
1 alkyl 2 acetyl sn glycerol cholinephosphotransferase
szeto schiller
heart failure and reduce ejection fraction
circulatory support
all cause hospitalization
lvad
myocyte
bat
lvh
adipokine
sarcomeric microstructure
cyclic guanosine monophosphate
chronic heart failure
proteomic remodeling
leave ventricular base
ivc occlusion
muscle
healthcare
holosystolic murmur
cholesterol
antihypertensive medication
rnas
systolic blood pressure
downregulate
cardiac vegf expression
transduction pathway
partial pressure of end tidal co2
nitroxyl
myocardial ischemia
heart
diastolic function
bromodomain containing protein 4
covariate
gem / kir
right atrial myxoma
pulmonary embolectomy
transseptal
epifluorescence microscopy
cell therapy
primary end point
mapk
bet
pump dysfunction
symptom
shotgun lc m / ms
abcd classification
aortic insufficiency
carcinoma
mitral regurgitation
murine
kinase
atrial
decompensated systolic heart failure
leave ventricular assist system
anemic
cardiac progenitor function
idiopathic
esrd
inotropic
ecmo
cardiovascular mortality
glucose
β adrenergic receptor
lactate
cox regression analysis
hek
ventricular systolic hf
palliation
physiologic
myocardial perfusion
stem cell
transcatheter aortic valve procedure
compliance
mass spectrometric analysis
myocty
chronic thromboembolic pulmonary hypertension
aor
genomic reprogramming
pdrelate
anthracycline induce cardiotoxicity
cpcs
cell senescence
dipeptidyl peptidase 4
cardioprotective signal
perioperative
biosynthetic enzyme
or
cri
3 vessel cad
biological phenotype
extracorporeal support
long axis function
apex
catheterization
dyspnea
angiogenesis
rv dysfunction
s1pr1s
human induce pluripotent stem cell derive cardiomyocytes
nesiritide
lvef
psychometric
acute rv failure
myocardium
brd4
cardiopulmonary exercise testing
cluster analysis
metabolism
resuscitation
interatrial shunting
resynchronization
outpatient
arni inhibitor
preserve lv ejection fraction
rheumatic fever
β adrenergic receptor blockade
coronary heart disease
beta blockade
arterial tonometry
nonselective β blocker
pulmonary vascular resistance
grade 4 / 6 holosystolic murmur
congenital
multivariable logistic analysis
myocardial oxygen consumption
ingenuity pathway analysis
nad \(p\) h oxidase
ischemic event
ecg
6 minute walk distance
end point
lipid
pacing induce chf
myosin
β1 adrenergic receptor
circulatory assist device
infusion
hospitalisation
nt pro bnp
leave pulmonary artery
neprilysin
healthy
pulse wave
crossover study
centrifugal flow pump
nyha functional class iii
operation
mineralocorticoid receptor antagonist
bridge to transplantation
cytoskeletal actin dynamics
at1
ahf
intravenous
bottleneck stenting
perfusion
strain
sonographic
nyha functional class ii
atrial fibrillation
\(123)i meta iodobenzylguanidine
plasma membrane translocation
thromboembolic event
hypertensive hfpef
plasma
atpase
mitochondrial target peptide
haematopoietic
ecct
ventricle
sepsis
nanog
genotype
s1pr1
chaga 's disease
vena cava
smad 2/3
artery
coronary
gtpase
t2d
chromatin associate protein
leave ventricular dilatation
glucocorticoid
renal artery stenosis
signal transduction
sympathovagal balance
epinephrine
allopurinol
cardiomyopathic
paco2
peak early diastolic mitral annular velocity
midpapillary
myocyte specific mena overexpression
nonischemic
paf ah
dual energy x ray absorptiometry
pka
esmolol
g protein coupling
human to machine interface
co morbidity
sst2
β coefficient
cytotoxic
intestinal
nps
kv4.3
qrs
sinus rhythm
comorbidity
energy substrate metabolism
n terminal pro b type natriuretic peptide
sensitivity
cpet
angiotensin converting enzyme inhibitor
chronotropic response
ischemic
secondary outcome
kidney infection
pulse
chf
systemic vascular resistance
c kit + cell
continuous flow
e / e '
ventricular dysfunction
fontan failure
anthracycline
beta adrenergic response
sodium
rheumatoid
transoesophageal echocardiography
health
wild type rad
aac
angiotensin convert enzyme inhibitor
2 vessel cad
chromatin subproteome
pathophysiology
inotrope
r blocker
plasma b type natriuretic peptide
coprimary end point
cardiac magnetic resonance imaging
ci
transform growth factor β
hepatic
aldactone
right ventricular
ventricularly
odd ratio
coronary artery ligation
antihyperglycemic drug
physiological
cardiac volume overload
rs synchrony
septal
interventricular septum
physical examination
thromboembolic
aldosterone receptor antagonist
cardiac transplant
non ischemic heart failure
portal hypertension
mir 25
oxidative stress
cardiac murmur
periodic breathing
redo sternotomy
cytoskeleton
univariate analysis
peak oxygen uptake
subcellular
svr
endothelial no synthase activation
echo doppler cardiography
sr
valvular disease
gls
implantable cardiac arrhythmia device
acute dyspnea
likelihood ratio
dxa
mri scanner
artery tonometry
double blind
trichrome blue histologic analysis
atrioventricular
tomographic angiography
interleukin receptor
leave ventricle
random effect model
extracorporeal membrane oxygenation
follow up duration
coronary artery calcium score
cox modeling
regression line
catabolic isoenzyme
hf ref
end diastolic pressure
ventricular tachycardia
ischemia
ischemic hypertensive cardiomyiopathy
systemic blood pressure
telemonitoring
n terminal probnp
lv compliance
ventricular diastolic function
phosphocreatine
coagulability
vascular disease
can \(2 +\) handling
edge to edge anastomosis
l type ca2 \(+\) current
mild heart failure
pathophysiological
sarcoplasmic reticular
acr
nfat
natriuretic
lv posterior wall
end diastolic volume index
raloxifene
irs1
cardiomyocyte bioenergetics
cardiovascular function
phenylephrine
leave ventricular function
nonmitochondrial protein
peak early diastolic mitral flow velocity
chf nyha iii
chronic advanced heart failure
s3991
ser96
follow up
inoperable
ischemic cerebrovascular event
cardiomyiopathy
tgf β receptor type i
bradyarrhythmias
histologically
neurohormonal
infection
cardiac
jq1
natriuretic peptide
ang ii
myocardial ischaemia
myofibrillar
peak quadricep force
pol ii
pneumonia
telehealth
disease risk score
angiotensin ii
stenotic physiology
aortic pressure
phosphomimic
implant
gly16/glu27
ion channelopathy
nonsignificant
right ventricular support
troponin
transmitral flow
acetylcholinesterase inhibition
heart block
denervation
intracellular
diuretic
pulmonary arterial hypertension
stable
coronary occlusion
cardiologist
short term fractal scale exponent
catheter
pediatric fontan
decompensated hf
pulmonary embolism
mitral leaflet motion
nyha ii
orally
arginine vasopressin
pyridostigmine
time up & go
venous thromboembolism
cardiac magnetic resonance
irs2
hr reduction
lipoprotein associated phospholipase a2
fully magnetically levitate lvas
capillary
nondiabetic
carotid intima media thickness
scn5a
atherosclerotic cad
subpulmonary ventricle
angiotensin
phosphodiesterase 2
angina
red blood cell
ctnt
electrocardiogram
lv contractile function
wall stress
covariate adjustment
aortic valve
curative
egfr
multivariate cox model
systolic mitral annulus velocity
oht
meta analyzed
diastolic murmur
acetylcholinesterase inhibitor
cronbach 's α
qt interval
combine end point
tumor
vascular endothelial growth factor
collagen deposition
antagonist
pathobiology
myofiber dynamics
paucity
septum
absorptiometry
central blood pressure
beta adrenergic receptor
right ventricular ejection fraction
spearman correlation
dobutamine
right ventricular dysfunction
transoesophageal echocardiographic
protein c
rvad
valvular regurgitation
enzyme
eov
metoprolol succinate
stroke
arg16/gln27
heart rate
pulmonary resistance
leave ventricular ejection time
vasodilator
leave ventricular ejection fraction
cardiorespiratory fitness
subvalvular
multivariable adjustment
ventricular
preserve leave ventricular ejection fraction
postsystolic function
antagomir
hypertrophy
metabolic
6 mwt
heart rate reduction
destination therapy
echo doppler
cc
right side cardiac catheterization
aldosterone antagonist
cardiac hypertrophy
natremia
randomise
β adrenoceptor blockade
calcineurin
rv failure
systolic leave ventricular dysfunction
venoarterial dilation
venous
rac2
cardiopulmonary bypass
extracorporeal life support
tug
8 fluo camp
progenitor
pacemaker
diabete
mammalian enable
kaplan meier analysis
prognosis
systolic volume index
adrenergic
dysfunction
sd of all qt interval
hand2
ventricular arterial coupling
lv function
rate ratio
c termini
neurohormones
serum potassium
rhythm control therapy
hyponatremia
immunoblotting
eccentric hypertrophy
system proteomic
b type np
mis
potassium
rv
therapeutics
rgk protein
right atrial
lv assist device implantation
arthritis
qol
tta/tgtetmena
nuclear factor of activate t cell
immunodetection
renin angiotensin system
homozygous
diastolic dysfunction
protein kinase a
qrs duration
pulsatile device
clinically
syndrome
cis
biventricular support
nf κb
endopeptidase
aldosterone receptor
bradycardic
exploratory factor analysis
significant
cell adhesion gene
l type ca2 + current
collateral growth
ss31
lusitropic
can \(2+\)
antihyperglycemic agent
functional ms
icu
sdrr
mitochondrial dysfunction
dyssynchronous hf
lvet
unilateral renal dnx
carotid
lv hypertrophy
tissue doppler
degenerative mr
ehrlich carcinoma
fill pressure
arrhythmias
rhythm control
serum albumin
psychosocial
stroke volume index
rem
neuro hormonal system
atp
frailty
myocardial ischemic event
nyha functional class iv
protein expression
malondialdehyde
cardiac event
multivariable analysis
p3 prolapse
ras blocker
case fatality rate
6 minute walk test
blood urea nitrogen
c index
end stage hf
2 way anova
chronic myocardial ischemia
pkc βii ser \(660\)
mr proanp
abdominal aortic constriction
infarct
endothelial cell
intensive care
wide qrs complex
red blood cell transfusion
adrenomedullin
leave ventricular hypertrophy
doxorubicin induce cardiotoxicity
hypertension
xo mediated ros
transseptal catheterisation
chamber
caspase 3
avd
systolic dysfunction
mitral valve opening
chronic systolic heart failure
receptor
thrombosis
renal underperfusion
heart failure
myocardial infarction
cad
blood glucose
molecular scaffold
diastolic fill time
fully magnetically levitate left ventricular assist system
chf nyha ii
cardiac looping
hemoglobin
bioprosthetic valve replacement
cardiac catheterization
benign tumor
in vivo coronary perfusion
tac
leu3
ca2+
cardiomyocytes
avp
β adrenergic receptor blocker
cgmp synthesis
comorbid
β2 receptor haplotype
linear model
neoangiogenesis
fontan circulation
mitochondrial
extend criterion cardiac transplantation
ventricular cardiomyocytes
cardiac defibrillator
endothelial function
leave heart twist
multiple myeloma
myofilament
bundle branch block
liver specific irs1 and irs2 double knockout
bp
cfa
lv diastolic dysfunction
stable hf
st segment elevation mis
leave bundle branch block
hno
physician
genomic
relative risk
myocardial
extra corporeal membrane oxygenation
symptomatic
hypertensive heart disease
antiarrhythmic
bleed
peripheral vascular disease
cpr
end stage heart failure
refractory cardiogenic shock
cardioprotection
brain natriuretic peptide
nyha class iiib
free wall cs
transient receptor potential cation channel m7
primary outcome
lesion
peripheral edema
antiarrhythmic drug
implantable defibrillator
triangular resection
genetic
vo2max
cox proportional hazard regression modeling
organ failure
central end systolic pressure
integrate discrimination improvement
end systole
macrophage
angiotensin ii receptor blocker
vo2
mitral stenosis
end systolic elastance
leave ventricular dyssynchrony
pro6
power spectral analysis
vegf inhibition
baroreflex activation therapy
endpoint
acute ischemic right heart failure
mass spectrometry
insulin
insignificantly
fatty acid
vascular stiffness
mirnas
positron emission tomography
jugular venous pressure
embolism
systemic
immunoprecipitation
renin angiotensin system blocker
methotrexate
vegf expression
speckle track echocardiography
acute kidney injury
be
n terminal pro brain type natriuretic peptide
pro adrenomedullin
leaflet
reperfusion
intubation
vasodilatory
isoelectric focus
right ventricular contractile function
cardiac rehabilitation
effector molecule
lv
pro b type natriuretic peptide
norepinephrine
creatinine
inflammation
reoperation
cardiac function
killip class
parasympathetic neurotransmission
prospective
histological
sympathetic control of heart rate
electron microscopy
autonomic nervous system
right heart failure
remote monitoring
end systolic
caspase
cardiac disease
rv function
isolate coronary artery bypass grafting
proof of principle cohort study
peak vo2
vad
biventricular pacing
s1pr1 agonist
tachycardia
nurse
endoplasmic reticulum
hypoxia
can \(2 +\) sensitivity
pulmonary artery systolic pressure
inpatient
prognostic
posterior wall infarction
invasive hemodynamic assessment
leave ventricular assist device
probnp
e wave
non cachectic chf
cardiac magnetic resonance postcontrast t1 time
cardiac sympathetic activity
beta blocker
b natriuretic peptide
epithelial
xanthine oxidase
mri
metabolic exercise
parasympathetic control
cpg
titrate
noninvasive
anabolic
drug treatment
student t test
pulsatile afterload
antiplatelet agent
secondary end point
diabetic
right ventricular pacing
multivariate model
enos thr \(495\)
raas
david
rad variant
lean mass
regression model
cerebral
myxoma
differentially express gene
acute right heart failure
nyha class
bolus
monomeric g protein
thrombotic obstruction
prolapse
diuretics
saxagliptin
diastolic tethering
hazard ratio
surgery
myocyte hypertrophy
right pulmonary artery
right heart
selective beta blocker
p70s6k
catabolic
mitral annular velocity
parasympathetic tone
acute
all cause hospitalisation
epigenetic
cardiac injury
blood transfusion
ic
chronic acf
global gene expression
cellular dysfunction
nonischemic cardiomyopathy
selective β blocker
chemotherapy
pulmonary
ambulatory
lv remodeling
rwt
to + channel
myocyte differentiation
heart failure with preserve leave ventricular ejection fraction
antiplatelet drug
anastomosis
proanp
hemostasis
energy metabolism
global left ventricular longitudinal systolic strain
mitochondrial respiration
basal heart rate
ref
anticoagulation
erc
clinical
functional capacity
hospitalize
muscle aerobic capacity
hipsc cms
propranolol
postexercise phosphocreatine resynthesis
hf with preserve ejection fraction
dyslipidemia
nbdmard
percutaneous coronary intervention
histone deacetylase
new york heart association classification
therapy
β adrenergic receptor agonist
actin cytoskeleton
implantation
blood flow
haemodynamic
haplotype
neurohormone
systole
rs10927887
ischemic mr
lcx
kappa coefficient
human embryonic kidney
log rank testing
camp
regression modeling
immunohistochemistry
ste
lv strain rate
sr can \(2 +\) pump
bhlh
readmission
ser83
western blot
anti neoplastic agent
rr
hyperlipidaemia
multisystem disease
mixed model
muscular
right ventricle
sdqt
intraclass correlation coefficient
auscultation
heart failure with reduce ejection fraction
peripheral oedema
pd
invasive
etiology
frail
inject
arni
right heart circulation
point of care
pb
myocardial collagen
embolectomy
renal denervation
hr variability
gastrointestinal
obesity
progenitor cell
uptitration
coronary revascularization
multiorgan failure
hypertensive heart failure with preserve ejection fraction
dcm
resynchronization therapy
neurohumoral blocker
end systolic volume
testosterone
stable heart failure
systolic elastance
retrospective cohort study
p value
lv dysfunction
anticoagulant
reduce ejection fraction
electrocardiographers
sphingosine 1 phosphate receptor 1
ventricular mass
renal impairment
cardioversion
myocardial function
medically
doppler mitral inflow velocity
qrs complex
\(123\) i mibg
interatrial shunt
venous thromboembolic event
continuous flow lvad
myocardial dd
implantable cardiac defibrillator
in vivo
hemodynamic phenotype
systemic hypertension
rheumatic
signal pathway
isoprenaline
aldosterone antagonism
pressure volume relation
gene
contractile
transverse aortic constriction
leave ventricular fill pressure
defibrillator
dilated cardiomyopathy
g protein couple receptor
ckd
therapeutic
secondary endpoint
β myosin heavy chain
cardiac cachexia
cardiology
correlation
cardiovascular disease
precapillary pulmonary hypertension
ischemic heart failure
proteolysis
co
cardiac washout
extracellular
downstream signal
hdl
nursing
rtq pcr
cardiac remodelling
lv ef
qtv
renin angiotensin aldosteron
confirmatory factor analysis
mitral annulus velocity
cf
transplant
inferior vena cava
myocardial remodelling
nyha iiib
exercise tolerance
cardiac failure
chop
chronic decompensated heart failure
transplantation
angioplasty
peripheral muscle pump
propensity score
pulmonary arterial systolic pressure
eo cfu
autonomic dysbalance
right heart fill pressure
pad
etiologic
nitrite
pathophysiologic
admission
cytochrome c
heart muscle
t1 time
urinary tract infection
pressure overload
pulmonary capillary wedge pressure
leave ventricular
vvd
l type current
bradycardia
pharmaceutically
cardiotoxicity
mitochondrial oxidative phosphorylation capacity
apoptotic cell
right ventricular assist device
rgk
eo cfus
cellular plasticity
ees
vegf receptor
downregulation
glycolysis
peak work rate
hfref
vasopeptidase inhibitor
h dko
multivariate cox regression analysis
stress echocardiography
copd
molecular dysfunction
arg76
interventricular delay
mitochondrial energy production
out patient
gdmt
ies
postcontrast t1
primary endpoint
lv diastolic stiffness
cardiovascular event
fibrillation
ph
atrial natriuretic peptide
vo2 max
signalosome complex
calcium sensitize agent
kaplan meier curve
osteoporosis
vo
preoperative
tm
multivariate regression
cardiac resynchronization therapy
cardiac fibrosis
ed
infarction
non dilated left ventricle
right ventricular function
contractile efficiency
ablation
p38alpha
amino terminal pro b type natriuretic peptide
pulmonary artery
implantable cardioverter defibrillator
fluid retention
c statistics
early outgrowth colony form unit
pde2
q65p
liver disease
pvf
donor
new york heart association class iii
nonprescribing
